Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001092602 | SCV001249167 | pathogenic | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | FAS: PVS1, PM2, PS3:Moderate, PP4 |
Labcorp Genetics |
RCV001856272 | SCV002174947 | pathogenic | Autoimmune lymphoproliferative syndrome type 1 | 2022-08-11 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 872242). This premature translational stop signal has been observed in individual(s) with autoimmune lymphoproliferative syndrome (PMID: 21490157, 22237435). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ala16*) in the FAS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FAS are known to be pathogenic (PMID: 10875918, 22237435). |
Institute for Clinical Genetics, |
RCV001092602 | SCV004026297 | pathogenic | not provided | 2023-03-28 | criteria provided, single submitter | clinical testing |